{"id":805206,"date":"2026-04-28T14:16:02","date_gmt":"2026-04-28T14:16:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=805206"},"modified":"2026-04-28T14:16:02","modified_gmt":"2026-04-28T14:16:02","slug":"nucleic-acid-isolation-and-purification-market-to-reach-1099-billion-by-2030-driven-by-ngs-expansion-and-precision-diagnostics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nucleic-acid-isolation-and-purification-market-to-reach-1099-billion-by-2030-driven-by-ngs-expansion-and-precision-diagnostics_805206.html","title":{"rendered":"Nucleic Acid Isolation and Purification Market to Reach $10.99 Billion by 2030, Driven by NGS Expansion and Precision Diagnostics"},"content":{"rendered":"
\"Nucleic<\/a><\/div>\n
Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs), Region – Global Forecast to 2030<\/div>\n

The global Nucleic Acid Isolation and Purification Market<\/a><\/strong> is projected to grow from $7.10 billion in 2025 to $10.99 billion by 2030, registering a CAGR of 9.1%. This growth is being fueled by the rapid expansion of Next-Generation Sequencing (NGS), molecular diagnostics, and personalized medicine, all of which depend on high-quality DNA and RNA extraction as a foundational step.<\/p>\n

Download PDF Brochure: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=229978287<\/a><\/strong><\/p>\n

As sequencing technologies scale across clinical and research environments, demand is rising for high-purity, inhibitor-free nucleic acid inputs. In response, vendors are advancing NAIP workflows with automation-ready formats, improved chemistries, and higher yield efficiencies, enabling laboratories to process larger volumes at lower cost per sample.<\/p>\n

However, adoption of high-throughput and automated extraction platforms remains constrained in some settings due to significant upfront investment, validation requirements, and workforce training needs.<\/p>\n

Kits Segment Drives Recurring Revenue and Market Stability<\/strong><\/p>\n

By product, kits accounted for the largest market share in 2024, reflecting the consumables-driven nature of nucleic acid extraction workflows.<\/p>\n

Their dominance is supported by:<\/p>\n